Fanizza, J.; D’Amico, F.; Lusetti, F.; Fasulo, E.; Allocca, M.; Furfaro, F.; Zilli, A.; Parigi, T.L.; Radice, S.; Peyrin-Biroulet, L.;
et al. The Role of IL-23 Inhibitors in Crohn’s Disease. J. Clin. Med. 2024, 13, 224.
https://doi.org/10.3390/jcm13010224
AMA Style
Fanizza J, D’Amico F, Lusetti F, Fasulo E, Allocca M, Furfaro F, Zilli A, Parigi TL, Radice S, Peyrin-Biroulet L,
et al. The Role of IL-23 Inhibitors in Crohn’s Disease. Journal of Clinical Medicine. 2024; 13(1):224.
https://doi.org/10.3390/jcm13010224
Chicago/Turabian Style
Fanizza, Jacopo, Ferdinando D’Amico, Francesca Lusetti, Ernesto Fasulo, Mariangela Allocca, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet,
and et al. 2024. "The Role of IL-23 Inhibitors in Crohn’s Disease" Journal of Clinical Medicine 13, no. 1: 224.
https://doi.org/10.3390/jcm13010224
APA Style
Fanizza, J., D’Amico, F., Lusetti, F., Fasulo, E., Allocca, M., Furfaro, F., Zilli, A., Parigi, T. L., Radice, S., Peyrin-Biroulet, L., Danese, S., & Fiorino, G.
(2024). The Role of IL-23 Inhibitors in Crohn’s Disease. Journal of Clinical Medicine, 13(1), 224.
https://doi.org/10.3390/jcm13010224
